Statistics
Publications
1
Citations
17
H-Index
1
Active since
2018
Affiliations
Yalin Zhu is an author at First Affiliated Hospital of Xinjiang Medical University specializing in pharmacology, molecular oncology, and oncology.
Publications per year
2018–2018
1
1
Gefitinib inhibits malignant melanoma cells through the VEGF/AKT signaling pathway
Xuefeng Wan, Yalin Zhu, Lijuan Zhang et al. · Molecular Medicine Reports · 2018 · 17 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1